Arvinas (ARVN) Interest Expenses (2017 - 2026)
Arvinas' (ARVN) quarterly Interest Expenses came in at $3.9 million in Q1 2026, down 66.95% year-on-year from $11.8 million in Q1 2025, and up 875.0% quarter-over-quarter from $400000.0 in Q4 2025.
Arvinas (ARVN) Interest Expenses (2017 - 2026) Analysis & Trends
Arvinas' Interest Expenses history runs 10 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- On a quarterly basis, Interest Expenses fell 66.95% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $3.9 million, a 66.95% decrease from a year earlier, with the FY2025 full-year figure at $481.4 million, up 2.12% from the prior year.
- Interest Expenses advanced to $3.9 million in Q1 2026 per ARVN's latest filing, from $400000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $11.8 million in Q1 2025 and bottomed at $400000.0 in Q4 2022.
- The 5-year median for Interest Expenses is $2.5 million (2025), against an average of $3.0 million.
- Across the five-year window, Interest Expenses plunged 99.75% in 2022 and surged 640.0% in 2023, its largest moves.
- Year by year, Interest Expenses stood at $400000.0 in 2022, then grew by 25.0% to $500000.0 in 2023, then soared by 260.0% to $1.8 million in 2024, then slumped by 77.78% to $400000.0 in 2025, then soared by 875.0% to $3.9 million in 2026.
- Per Business Quant, the three latest ARVN Interest Expenses figures stand at $3.9 million (Q1 2026), $400000.0 (Q4 2025), and $2.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | 3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.90 Mn |
| Mar 31, 2026 | 3.90 Mn |
| Dec 31, 2025 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 11.80 Mn |
| Mar 31, 2025 | 11.80 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 900,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |